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The ability ofa vertebrate to recognize microorganisms as foreign and elimi-
nate them is critical for host survival. For pathogens that enter via the mucosal
surface, studies have shown that the prevention of adherence or colonization
decreases the likelihood of their causing disease (1). To limit colonization, both
specific and nonspecific defense mechanisms that act at mucosal surfaces consti-
tute the first line ofdefense against infectious agents (1, 2).
Since the discovery of IgA, much research has been aimed at determining the
mechanism of stimulating the expression and secretion of this mucosally associ-
ated immunoglobulin. Peyer's patches (PP),' which constitute the organized
lymphoid follicles found within the walls of the small intestine, contain a unique
microenvironment that allows for the generation of an antibody response domi-
nated by IgA-committed B cells. IgA-committed precursor cells, generated by
interaction of antigen with the lymphoid elements present in PP, enter the
circulation, mature, and eventually repopulate the lamina propria of mucosal
surfaces with IgA-secreting plasmablasts (3-5). It appears that antigens that
impinge on mucosal surfaces and interact with PP are especially efficient at
generating anantibody response dominatedby IgA (6). Recent datahas suggested
that T cell subsets are present in PP that are capable of influencing the isotype
expression of B cells. Two such T cell populations have been described by
McGheeandcoworkers (7-10). The first population has been shown to recognize
and interact with IgA-committed B cells to allow them to mature into IgA-
secreting plasma cells (7, 8). The second population, described as IgA-specific
contrasuppressor T cells, allow an IgA plaque-forming cell response to occur in
the spleens of mice rendered tolerant by previous oral immunization (9, 10).
While PP contain T cells that appear important for the generation ofan IgA
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response, the generation of cytotoxic T cells (CTLs) to non-major histocompat-
ibility complex (MHC)-encoded (nominal) antigens in PP has not been demon-
strated. Since CTLs have been shown to be important in the resolution of viral
infections (11-13), it is of interest to examine the ability of mucosal tissues to
generate a CTL response. Such a response may be critical for the effective
control of infections initiated at mucosal surfaces, because subsets of T cells may
differ in their preferred recirculation pathways (14), and those primed in the
mucosa may have a propensity to return there to aidin theresolution of infection.
To analyze such mucosal priming, we have used reovirus serotype 1, strain Lang
(reovirus I/L) as a probe to determine whether murine PP are capable of
supporting the generation of a virus-specific CTL response. Reovirus 1/L was
chosen for these studies for the following reasons: (a) reovirus I/L is a naturally
occurring enteric virus that is stable within the gastrointestinal tract (15); (b)
priming for reovirus-specific CTLs has been shown to occur in the murine spleen
in response to intraperitoneal immunization with virus (16); and (c) reovirus 1/L
preferentially binds to and is transported from the intestinal lumen into PP
through microfold (M) cells (17, 18), thereby allowing interactions to occur
within the patch between virus, antigen-presenting cells, and lymphocytes. Our
initial findings (19) have shown that the enteric application of reovirus I/L
results in detectable virus-specific IgA antibodies in intestinal secretions. In this
paper, we have examined the clonal B cell response generated in vitro by cells
primed in vivo with reovirus 1/L. We found that a high proportion of B cell
clonal precursors obtained from PP and the spleen after intraduodenal immu-
nization are precommitted to IgA production when they are stimulated in vitro
in the splenic focus assay. Therefore, reovirus I/L appears to be an efficacious
mucosal antigen.
We also report that a single intraduodenal application of reovirus 1/L is
capable of generating detectable levels of virus-specific cytotoxicity in PP lym-
phocytes upon in vitro restimulation. Such effectors show the surface phenotype
of CTLs (Thy-1 +, Lyt-2''), are MHC-restricted, and virus specific. Furthermore,
the local generation in the PP of the CTL response is suggested by the finding
that the intraduodenal application of reovirus I/L generates higher levels of
virus-specific CTLs in the PP as compared to peripheral lymph nodes (PLN) 2
or 6 d after immunization. Virus-specific CTLs can be detected in PP 6 mo after
a single enteric application of reovirus I/L, indicating a long-lived memory
response.
Materials and Methods
Mice.
￿
Male C3HeB/Fej and CBA/J (H-2k
) and DBA/2J (H-2d) mice were purchased
from TheJackson Laboratory, Bar Harbor, ME. BALB/c (H-2a) mice were bred in our
animal facility. These mice were housed in isolators, and screened on a regular basis for
reovirus antibody. Virally primed mice were kept physically isolated from all other
experimental and stock mice. 6-12-wk-old mice were used in all experiments. Lymphoid
tissues from three mice were pooled for each experiment.
Cell Lines.
￿
The following cell lines were used in these studies: L-929 (H-2k) fibroblast
cells, L-929 cells transfected with H-2D' (DM-1) and H-2L° (LM-1) genes (obtained from
Drs. J. Weis and J. Seidman, Harvard Medical School, Boston, MA) (20), the B10.D2
simian virus 40-transformed kidney line KD2SV (obtained from Dr. B. Knowles, The832
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Wistar Institute, Philadelphia, PA) (21), and the A/Sn-derived Moloney virus-transformed
T cell lymphoma Yac-1 .
Viruses.
￿
Reovirus 1/Lang (1/L) and reovirus 3/bearing (3/D) clones were originally
obtained from Dr. Bernard Fields (Harvard Medical School, Boston, MA). We have
recloned these parental stocks on L cell monolayers, and used gradient-purified third-
passage stocks, titered by limiting dilution on L cell monolayers (22). These viral stocks
manifest the characteristic dsRNA (double-stranded RNA) banding patterns associated
with type 1/L or 3/D reovirus, as determined by polyacrylamide gel electrophoresis (23).
Vaccinia virus (WR isolate) was kindly provided by Dr. J. Bennink (The Wistar Institute,
Philadelphia, PA).
In Vitro Generation of Virus-specific CTLsfrom Spleen.
￿
Splenic CTLs were generated in
vitro from mice primed in vivo with reovirus 1/L (24) or vaccinia virus (25) following
previously published protocols. Cells were cultured in a 5% C02 atmosphere in complete
medium consisting of RPMI-1640, 25 mM Hepes supplemented with 50 wg/ml gentamy-
cin, 2 mM glutamine, 10% FCS (Gibco Laboratories, Grand Island, NY) and 5 X 10-5 M
2-ME (Sigma Chemical Co., St. Louis, MO).
In Vitro Generation of Virus-specific CTLs from Peyer's Patches.
￿
Enterically primed mice
were immunized by the intraduodenal application of 3 X 10' PFU of reovirus 1/L
suspended in 0.5% gelatin (J. T. Baker Chemical Co., Phillipsburg, NJ) dissolved in PBS
(gel saline) after a small laparotomy (6). Control mice were subjected to the same surgical
procedures and injected with gel saline alone. 1 wk after priming, a single-cell suspension
of PP lymphocytes was obtained. 2 X 105 lymphocytes for bulk cultures, or varying
numbers for limiting-dilution cultures, were added per well of a 96-well round-bottomed
microtiter plate (Nunc, Roskilde, Denmark) in the presence of 5 X 10' virally pulsed
peritoneal exudate stimulator cells (PECs). PECs were obtained from syngeneic mice that
had received a single intraperitoneal injection of 1 .5 ml of thioglycolate medium without
indicator (BBL Microbiology Systems, Cockeysville, MD) 3-4 d before being harvested
by peritoneal lavage with 10 ml of HBSS (Gibco Laboratories). Harvested PECs were
virally pulsed at a multiplicity of infection (MOI) of one for I h, during which they were
exposed to 1,600 rid of y-radiation from a cobalt source. On the following day, Con A-
conditioned medium at a final concentration of 10% was added and the cultures were
harvested after 6 d for bulk cultures, or 8 d for limiting-dilution cultures. The preparation
of conditioned medium has been previously described (26). Live lymphocytes were
obtained from bulk cultures by Ficoll/Isopaque centrifugation (27).
Cytotoxicity Assay.
￿
A standard "Cr-release assay, using various E/T ratios, was used to
measure cell-mediated cytotoxicity (28). Assays were performed in 96-well V-bottomed
microtiter plates (Nunc) in a 5% C02 incubator for 5 h. All assays were performed in
triplicate.
Yac-1, P-815, or LPS blasts were labeled with "Cr by overnight incubation at 37°C
with 200,uCi of Na5 'Cr (Amersham Corp., Arlington Heights, IL) in complete medium.
LPS blasts were obtained by Ficoll/Isopaque centrifugation (27) of splenocytes cultured
for 2 d in the presence of 50 ug/ml of Escherichia coli serotype 0111 :B4 LPS (Sigma
Chemical Co.). L cells, the transfected L cell lines DM1 and LM1, or KD2SV cells were
infected with reovirus at an MOI of five before overnight culture in T-25 tissue culture
flasks (Costar, Cambridge, MA) at 31 °C (L cells) or 37°C (transfected L cells or KD2SV
cells) in the presence of 200 ACi of Na5'Cr (Amersham Corp.). Adherent targets were
released by incubation with versene (EDTA) solution. Vaccinia virus-infected L cell
targets were prepared as previously described (25).
Complement-mediated Cell Lysis.
￿
30H12 (anti-Thy-1) (29) and 3.155 (anti-Lyt-2) (30)
monoclonal antibodies were used to lyse effector cells before assay. Equal volumes of
cultured lymphocytes, undiluted antibody (acid supernatant), and a 1 :5 dilution of rabbit
complement were incubated at 37°C for 45 min. Cells were washed twice before being
assayed. Control cells were incubated with complement alone.
Limiting-dilution Analysis.
￿
Replicate microculture wells (n = 20), containing varying
numbers of either PP or PLN lymphocytes obtained from mice intraduodenally stimulated
with reovirus 1/L, were stimulated in vitro as described. After an 8-d culture period, theLONDON ET AL.
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contents of individual microtiter wells were resuspended and divided into two portions in
V-bottomed 96-well microtiter plates (Nunc), and assayed for cytotoxic activity vs. either
reovirus 1/L infected or uninfected L cells. Cultures were considered to demonstrate
cytotoxicity to a particular target ifthe resultant "Cr release was three standard deviations
above control levels. Individual microcultures, tested for cytotoxicity against infected and
uninfected L cells, were considered to be virus specific if the "Cr release was two- to
threefold higher against infected vs. uninfected L cell targets. The fraction of microcul-
tures at particular input cell doses that did not generate virus-specific cytotoxicity was
used to calculate the precursor CTL frequency by the maximum likelihood method (31).
This calculation also generates a p value, which determines whether the calculated
frequency is consistent with single-hit kinetics. Frequencies with an associated p value
>0.05 are consistent with single-hit kinetics and are considered valid by the maximum
likelihood calculation.
Clonal Assayfor Reovirus-specific B Cells.
￿
Frequencies of reovirus-sensitive B cells were
determined by the splenic focus assay (32). Splenocytes from BALB/c mice, immunized
10 wk previously by the intraperitoneal injection of 3 X 10' PFU of reovirus 1/L, or PP
lymphocytes, and splenocytes from BALB/c mice immunized by the intraduodenal appli-
cation of 3 X 10' PFU of reovirus 1/L 4 wk previously, were analyzed. Limiting numbers
ofcells were injected into the tail veins of reovirus 1/L-primed (3 X 10' PFU in CFA for
>10 wk), lethally irradiated (1,600 rad) recipients. After 16 h, recipient spleens were
removed and diced. The resultant fragments were distributed into 96-well flat-bottomed
microtiter plates (Costar). Each fragment was challenged with 2 X 109 particles of UV-
inactivated reovirus 1/L (33). Excess antigen was removed from culture on day 4 and
supernatants were collected on days 7, 10, and 13 for analysis by RIA for reovirus-specific
antibodies.
RIA.
￿
A solid-phase RIA was used to detect reovirus-specific antibodies. Reovirus 1/L
was suspended at 4.8 X 10" particles/ml in NaHC03 buffer, pH 9.5. 25 I,1 were added
per well to 96-well vinyl microtiter plates (Costar) for 16 h at 4°C. These plates were then
used to identify supernatants containing reovirus-specific antibodies with '2sI-labeled
rabbit anti-mouse Fab or rabbit anti-mouse isotype scoring reagents generated in our
laboratory (34).
Results
B Cell Response after Introduodenal Immunization with Reovirus Serotype
11L. The generation of a reovirus-specific B cell response was investigated at
the clonal level by means of splenic fragment cultures. We found that 4 wk after
the intraduodenal application of reovirus 1/L, a high proportion of clones,
obtained from either the spleen (61 %) or PP (73%), were secreting IgA antibodies
specific for reovirus (Table I). Further, the majority of these clones were
synthesizing IgA exclusively. In comparison, mice stimulated by the intraperito-
neal injection of reovirus I /L produce a B cell response that is dominated by
IgG-secreting clones (86%) with few clones exclusively making IgA (Table I).
Although the isotype profile exhibited after intraduodenal immunization was
markedly skewed toward IgA production, similar rises in frequencies of clonal
precursors from normally low levels (<1/106) were observed regardless of the
route of viral inoculation. These results demonstrate that, by the criterion of B
cell priming, reovirus is an efficacious immunogen when applied intraduodenally.
Virus-specific Cytoxic Activity Is Found in PP after Intraduodenal Application of
Reovirus Serotype 1 . To investigate CTL responsiveness after mucosal challenge,
an in vitro culture system, in which precursor CTLs (pCTLs) could expand into
effector CTLs, was used. 6 d after the intraduodenal application of 3 X 107 PFU
of reovirus 1/L, significant levels of cytotoxicity were generated in vitro from834
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TABLE I
Frequencies and Isotype Profile ofReovirus-specfic MemoryB Cells
* Donormice were primed by intraperitoneal injection of 3 X 107 PFUof
reovirus I/L 10 wk before sacrifice .
Donor mice were primed by the intraduodenal injection of 3 X 10 7 PFU
of reovirus 1/L 4 wk before sacrifice.
A Frequencies were calculated assuming 60% B cells were in PP, 40% in
the spleen, and that 4% of donor cells lodge in the spleen of recipient
mice .
FIGURE 1 .
￿
Cytotoxic activity of PP lymphocytes . PP lymphocytes obtained from C3H mice
primed intraduodenally with reovirus (a, c, e) or control mice (b, d,f) were stimulated in vitro
with reovirus I/L and conditioned medium (a, b), reovirus 1/L alone (c, d) or conditioned
medium alone (e,f) . After 6 dof culture, cytotoxic activity was tested using uninfected L cells
(solid bars) or reovirus 1/L-infected L cells (stippled bars) as targets .
PP lymphocytes (Fig. 1 A) that were comparable to those obtained from paren-
terally immunized splenocytes (data not shown) . PP cells from mice that had
received an intraduodenal application of gel saline without virus did notproduce
a virus-specific cytotoxic response (Fig . 1 B) . However, PP cellsfrom both primed
and control mice produced detectable levels of cytotoxicity to uninfected L cells
(Fig . 1, A and B) . This cytotoxicity against L cells was dependent on the addition
ofconditioned medium to the culture system and not reovirus 1/L . PP cells from
primed mice stimulated without the addition of conditioned medium produced
virus-specific cytoxicity without detectable levels of cytotoxicity to uninfected L
Isotype
expressed
Clones
given
Spleen*
expressing
isotype in :
Spleen* PP$
Some IgM 4.5 33 18
Some IgG 86 14 9
Some IgA 36 61 73
IgA only 9 50 64
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FIGURE 2. T cell help is required for the generation of virus-specific CTLs in in vitro
cultures. Replicate microcultures seeded with the indicated numbers of input cells/well were
stimulated in vitro in the presence (0) or absence (0) of 10% conditioned medium. After 8 d
of culture, individual microculture wells were tested for virus-specific cytotoxic activity.
cells, while control PP lymphocytes produce cytotoxicity to neither infected nor
uninfected L cells (Fig. 1, C and D). Conversely, primed or control PP lympho-
cytes cultured in the presence of conditioned medium alone produced substantial
levels of cytotoxicity to L cells, regardless of viral infection (Fig. 1, E and F).
Primed or control PP lymphocytes cultured in the absence of conditioned
medium and virus produced no detectable levels ofcytotoxicity to either infected
or uninfected L cells (data not shown). Therefore, reovirus-specific cytotoxic
effector cells can only be generated in vitro from PP that have been stimulated
in vivo with reovirus.
Virus-specific Helper Activity Is Found in PP after Intraduodenal Application of
Reovirus Serotype 11L. Addition of an exogenous source of interleukin 2 (con-
ditioned medium) increased the level of virus-specific lysis generated in nonlim-
iting cultures, although its presence was not an absolute requirement (Fig. 1, A
vs. C). However, in limiting-dilution cultures, the generation of a virus-specific
response was shown to be absolutely dependent upon factors present in condi-
tioned medium. Individual microcultures seeded with limiting numbers of
primed PP lymphocytes were assayed for the generation ofvirus-specific cytotoxic
activity. Low input numbers of responding cells (6 X 10' cells/well) did not
generate virus-specific cytotoxicity when cultured in the absence of conditioned
medium. However, 100% of such microcultures generated virus-specific cytotox-
icity when cultured in the presence of 10% conditioned medium (Fig. 2). The
ability of nonlimiting (bulk) cultures of primed PP to generate virus-specific
cytotoxic activity without the addition of helper factors indicates that virus-
responsive helper cells are present in PP 6 d after intraduodenal stimulation.
Characterization of the Cytotoxic Potential ofPP Lymphocytes.
￿
Because we have
observed cytotoxic activity against uninfected L cells in the experiment shown
in Fig. 1, we chose to assay bulk-cultured PP lymphocytes against additional
targets (Fig. 3). While cytotoxicity to uninfected L cells was minimal in this
experiment, significant cytotoxicity to both reovirus I /L- and 3/D-infected L
cells was observed. In addition, intermediate levels of killing of the natural killer
cell (NK) target, Yac-1 were detected. However, both allogeneic and syngeneicsas CYTOTOXIC T CELL RESPONSE IN PEYER'S PATCHES
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FIGURE 3. Cytotoxic activity of reovirus 1/L-primed PP lymphocytes. PP lymphocytes
obtained from intraduodenally immunized mice were stimulated in vitro and effectors were
tested at a 50:1 E/T ratio for cytotoxic activity to the NK target Yac-I, syngeneic (CM) or
allogeneic (BALB/c) LPS blasts, uninfected L cells, andreovirus I/L-or 3/D-infected L cell
targets.
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FIGURE 4.
￿
Cytotoxicactivity ofreovirus 1/L-primed splenocytes. Splenocytes obtained from
intraperitoneally immunized CM mice were stimulated in vitroandeffectors were tested for
cytotoxicactivity to thefollowing targets: uninfected L cells (A), reovirus 1/L-infected L cells
(O), reovirus 3/13-infected L cells("), Yac-I cells (A).
LPS blasts were not significantly lysed. Age-matched control mice gave PP cells
that exhibited comparable levels of cytolysis to the NK target Yac-1 when
cultured in the presence of conditioned medium (data not shown), indicating
that the ability to lyse Yac-1 target cells is not a result ofviral priming.
We analyzed splenocytes obtained from intraperitoneally immunized mice to
determine whether they also generated cytotoxic lymphocytes that were not
serotype-specific, as well as cytotoxicity to the NK target Yac-1. We found that
primed splenocytes restimulated in bulk culture also efficiently lyse both reovirus
1/L-and 3/D-infected targets, and exhibit significant cytotoxicityto Yac-1 targets
(Fig. 4). This demonstrates that in vitro-cultured lymphocytes, derived from
either PP or spleen, can generate both reovirus-specific cytotoxic cells that do
not distinguish reovirus serotype as well as cells that kill NK targets.
To examine the surface phenotypic markers of the reovirus-specific effectors
generated in in vitro cultures obtained from primed PP, monoclonal antibodies
to T cell determinants plus complement were used to eliminate subpopulations
ofeffector cells. Substantial reduction ofcytotoxicity against reovirus-infected L
cells (reovirus 1/L or 3/D) was obtained by treatment ofeffector cells with eitherLONDON ET AL.
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FIGURE 5 .
￿
Thesurface phenotypeof cytotoxic effector cells . PP lymphocytes obtained from
intraduodenally immunized CM mice were stimulated in vitro for 6 d . Effectors were
harvested and pretreated with complement alone (light bars) anti-Thy-1 + complement (dark
bars) or anti-Lyt-2 + complement (black bars) and tested for cytotoxic activity against the
indicated targets . Results are the mean t SE of three experiments . Reovirus 1/L-infected L
cells were used as targets in all experiments, and reovirus 3/D-infected L cells were used in
two of the three experiments .
anti-Thy-1 or anti-Lyt-2 monoclonal antibodies plus complement (Fig . 5), indi-
cating that the virus-specific cytotoxicity was generated by effectors bearing the
surface phenotype of CTLs . Cytotoxicity to the NK target, Yac-1, was little
affected by treatment with anti-Thy-1 or anti-Lyt-2 monoclonal antibodies plus
complement . These findings indicate that a separate population of effector cells
mediate cytotoxic activity against L cells virally infected with either reovirus I /L
or 3/D, as opposed to that against Yac-1 targets .
The MHC restriction of PP-derived cytotoxic effector cells was analyzed in
the experiment shown in Fig . 6 . Reovirus-specific cytotoxic cells were generated
from C3H (H-2') and DBA/2 (H-2d) PP that were stimulated by intraduodenal
application of reovirus I/L 6 d previously . These primed effector cells, restim-
ulated in vitro, were then assayed for virus-specific cytotoxicity against a panel
of H-2' or H-2d cell lines infected either with reovirus 1/L or 3/D . As shown in
Fig . 6A, CM effectors efficiently lyse both reovirus 1/L- and 3/D-infected L
cell targets . However, these same effectors were unable to lyse the H-2d line,
KD2SV, when infected with either reovirus 1/L or reovirus 3/D (Fig . 6B) . In
contrast, DBA/2J (H-2d) effectors, which do not lyse reovirus 1/L- or 3/13-
infected L cells (Fig . 6A), are capable of lysing reovirus 1/L- or 3/D-infected
KD2SV targets (Fig . 6B) . Further, both these DBA/2J effectors as well as C3H
effectors are capable of lysing L cells that have been transfected with H-2d class
1 genes if they are infected with either serotype of reovirus (Fig . 6 C) . The ability
of DBA/2J effectors to lyse reovirus-infected L cells that simultaneously express
syngeneic class 1 molecules clearly demonstrates that class 1 MHC molecules
serve as the restriction element for PP-derived cytotoxic effector cells .
PP lymphocytes, stimulated in vivo and in vitro with reovirus serotype 1/L,838
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FIGURE 6. PP CTLs are H-2 restricted. PP lymphocytes, obtained from intraduodenally
primed CM (H-2"; closed symbols, solid lines) or DBA/2J (H-2d; open symbols, dashed lines) mice,
stimulated in vitro and effectors were tested for cytotoxic activity to uninfected targets (Q),
reovirus I/L-infected targets (O), or reovirus 3/D-infected targets (A). In A, the targets are
L cells (H-2'), in B the targetsare KD2SVcells (H-2d), and in C the targetsare a 1:1 mixture
ofthe H-2d-transfected L cells DM-1 and LM-1 .
were assayed for their ability to lyse either normal, reovirus-infected or vaccinia
virus-infected L cell targets (Fig. 7A). We found that these effectors were
cytotoxic for reovirus-infected, but not vaccinia virus-infected L cells. In con-
trast, splenocytes primed in vivo and in vitro with vaccinia virus were cytotoxic
for vaccinia virus-infected but not reovirus-infected L cells (Fig. 7B). These
observations demonstrate that reovirus-specific CTLs are not crossreactive with
unrelated viral antigens.
Virus-speck Cytolytic Activity Is More Pronounced in PP than in Peripheral Lymph
NodesAfterIntraduodenal Stimulation. We have demonstrated that virus-specific
CTLs can be generated from PP 6 d after intraduodenal application of virus.
We examined the level of virus-specific cytotoxicity obtained from cultures of
PP, mesenteric lymph nodes (MLN), spleen, and PLN 6 d (Fig. 8A) or 2 d (Fig.
8B) after intraduodenal application of reovirus I/L. In both cases, substantially
higher levels of cytotoxic activity to reovirus-infected L cells were generated
from PP as compared with PLN and spleen. MLN contained substantial cytotoxic
activity at 2 d, and intermediate levels of cytotoxicity at 6 d.
Limiting-dilution analysis was performed to determine whether the difference
in responsiveness of various lymphoid tissues observed in nonlimiting cultures
was related to the frequency of precursor CTLs. While we did not detect virus-40 :1 20:1 10:1 5:1 2.51 1.25:1
Effector : target ratio
FIGURE 7 .
￿
Reovirus-reactive CTLs are not crossreactive with unrelated viral antigens . PP
lymphocytes obtained from C3H mice stimulated intraduodenally with reovirus 1/L (A) or
splenocytes obtained from CBA mice stimulated intravenously with vaccinia virus (B) were
cultured in vitro with the immunizing virus, and effectors were tested for cytotoxic activity to
uninfected L cells (Q), reovirus 3/D-infected L cells (0), and vaccinia virus-infected L cells
FIGURE 8. Tissue distribution of reovirus-specific cytotoxic activity . PP lymphocytes (0),
MLN lymphocytes (Q), PLN lymphocytes (A), or splenocytes (") were tested 6 d (A) or 2 d (B)
after intraduodenal immunization with reovirus 1/L for virus-specific cytotoxic activity.
839840
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FIGURE 9.
￿
Limting-dilution analysis ofpCTL frequencies . 6 d after intraduodenal immuni-
zation, the frequency of pCTLs present in PP and PLN was analyzed by limiting-dilution
analysis. The shaded areas represent the 95% confidence limits of the maximum likelihood
estimates .
specific pCTLs from any lymphoid tissue of control animals (data not shown),
PP obtained from mice intraduodenally primed with reovirus 1/L 6 d previously
showed a precursor frequency of 67/106 PP lymphocytes (Fig . 9 and Table 11) .
The frequency of reovirus 1/L-specific pCTLs obtained from PLN was 14 .6-
fold lower (4.6/106 ) than that occurring in PP (Fig . 9 and Table I1) . We have
also examined the presence of virus-specific pCTLs in PP and PLN 6 mo after
intraduodenal immunization with reovirus 1/L . We found that pCTLs were
present in both tissues, with a 2 .2-fold higher frequency detectable in PP (50/106)
as compared to PLN (23/106 ) (Table I1) .
Discussion
In this report we have examined the ability of intraduodenally administered
reovirus 1/L to perturb, in an antigen-specific manner, both T and B cell subsets
that occur in PP . Because reovirus I/L selectively enters PP via M (microfold)
cells (17, 18), we postulated that it would be an efficacious mucosal immunogen
capable of expanding the numbers of virus-specific T and B cells in this location .
The finding ofhigh frequencies ofIgA-committed memory cells in PP and spleen
after intraduodenal but not intraperitoneal application of this virus confirmed
its effectiveness and implicated the PP as the site ofpriming. We have previously
reported that this process of IgA priming occurs naturally for certain antigenic
determinants associated with normal gut-commensal organisms, such as phospho-
choline and inulin (35, 36), and can be duplicated when germ-free animals,LONDON ET AL.
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TABLE Il
Frequencies ofReovirus-specific pCTLsPresent afterIntraduodenal
Immunization
* Frequency and p values were calculated by the maximum likelihood
method (31).
Absolute frequencies were normalized to the proportion of Thy-1* cells
present in PP (25%) and PLN (75%) as determined by flow-cytometric
analysis.
Absolute frequencies were normalized to the proportion of Lyt-2* cells
present in PP (6%) and PLN (25%) as determined by flow-cytometric
analysis.
Donormice were primed by theintraduodenal injection of 3 X 10' PFU
of reovirus I/L 6 d before sacrifice.
' Donormice were primed by the intraduodenalinjection of 3 X 107 PFU
of reovirus l/L 6 mo before sacrifice.
which have low frequencies of B cells specific for these determinants, are
colonized with normal gut-commensal organisms (36, 37). This process of IgA
priming can also occur when nonenvironmental antigens are applied via the
mucosal route. To date, cholera toxin has been found to be the most efficacious
nonenvironmental antigen for generating an IgA-committed B cell response in
PP after mucosal application (6). While the ability of cholera toxin to generate
an IgA-committed response may be related to its pharmacological properties
(38), it has also been hypothesized that its ability to avidly bind to gut mucosal
surfaces through ganglioside GMI (39) and to be selectively absorbed by the
dome epithelium (40) may be a critical determinant in allowing entry into the
patch, with subsequent generation of a B cell response dominated by IgA-
committed clones. Our current finding that reovirus 1/L effectively stimulates a
virus-specific IgA response further demonstrates that, for antigens that do not
chronically persist in the gut, binding to the dome epithelium overlying PP may
be crucial for the generation ofIgA memory B cells. Whether the effectiveness
of enterically-applied reovirus 1/L at priming for an IgA response is related to a
specific interaction between viral surface. proteins and receptors on M cells is
currently under investigation.
Our observation that PP are capable ofgeneratinga CTL response to nominal
(virus encoded) antigens extends earlier observations that CTL activity directed
against MHC differences can be generated in secondary MLR cultures of PP
lymphocytes from either normal mice or mice that had been chronically fed
allogeneic tumor cells (41, 42). No CTL response occurred in PP when mice
were chronically fed tumor cells bearing minor histocompatibility differences
(42). While these earlier studies demonstrated that a CTL response could occur
in PP, the generation ofallospecific CTLs, whose precursors are present at high
Tissue
Frequency
(per 106
cells)*
p normalized
Thy-l'*
Frequencies
to:
Lyt-2* I
PP' 67 0.3345 270 1,675
PLNI 4.6 0.6301 6 17
PP' 50 0.0931 200 1,235
PLN' 23 0.7480 28 85$42
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frequency among normal Tcells (43), may not be representative ofthe potential
of PP to generate CTLs specific for nominal antigens. More recently, it was
inferred (44) that virus-specific CTLs are generated in rat PP after the enteric
administration of vaccinia virus. Virus-specific helper T cells and CTLs were
found in MLN, butnot PLN, after enteric application ofvaccinia virus. However,
cytotoxic or helper activity was not detected in PP at any time after enteric
immunization . It was inferred that the virus-specific T cells that were found in
the MLN after enteric priming were derived from precursors locally primed in
the patches. Because our data demonstrate that virus-specific helper T cells and
CTLs can occur in PP, it is likely that a vaccinia virus-specific T cell response
also occurred in this system . We feel that we were successful in detecting a CTL
response to nominal antigens in PP, while others have failed, in part because we
used a more sensitive assay system that depends on expansion ofeffector CTLs
by in vitro restimulation after viral priming in vivo. The ability of reovirus to
generate both a virus-specific helper and CTL response further demonstrates its
efficacy as a mucosal immunogen.
In our characterization of PP-derived CTLs, we found that while the virus-
specific cytotoxic cellswerenotselective for theimmunizing serotype ofreovirus,
they were not crossreactive with unrelated viral antigens. This lack of serotype
specificity is in contrast to previous studies, which reported that reovirus-specific
CTLs derived from the spleen after intraperitoneal immunization predominantly
recognized serotypically unique determinants expressed on the viral hemagglu-
tinin (16, 24, 45). We found that the lack of serotype specificity was not unique
to PP but was also displayed by intraperitoneally primed splenocytes. Thus, the
discrepancyisnotduetothe tissue source ofthepCTLsand remains unexplained.
We feel that the CTL activity observed in PP was locally generated. In
nonlimiting cultures, significantly higher levels ofvirus-specific cytotoxicity were
observed from PP as compared to PLN 2 or 6 d after intraduodenal immuniza-
tion. Our observation that PP also contain virus-specific helper activity after
intraduodenal priming demonstrates that they contain the cellular elements
required for the generation ofeffector CTLs. The finding ofvirus-specific CTLs
in the MLN after intraduodenal immunization is a likely result ofdissemination,
via lymphatic drainage from PP, of either activated CTLs or infectious virus.
Because the finding ofa minimal response in PLN after enteric priming implies
that the route ofimmunization may be an important determinant in the gener-
ation ofa mucosal vs. peripheral T cell response, it was necessary to determine
whether the differences in responses seen in nonlimiting cultures were in fact
related to the precursor frequencies present in these tissues. We found a 14-fold
higher precursor frequency in PP as compared to PLN 6 d after enteric
immunization. The divergence in frequencies present in PP vs. PLN becomes
more pronounced when these arenormalized tothe proportion ofT cells present
(determined by flow-cytometric analysis), as PP contain fewer Tcells (25% Thy-
1+, 6% Lyt-2') as compared to PLNs (75% Thy-1+, 25% Lyt-2+). When normal-
ized to the proportion of Thy-1' cells, a 45-fold difference is observed, whereas
the difference is 100-fold when normalized to Lyt-2' cells (Table 11). Because
we have demonstrated such a discrepancy in the frequency ofpCTLs present 6
d after enteric immunization, we have examined these tissues for virus-specificLONDON ET AL.
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pCTLs 6 mo after the single intraduodenal application of 3 X 10' PFU of
reovirus 1/L (Table II). We found a detectable CTL response in both PP and
PLN at this time, with a twofold higher frequency in PP as compared to PLN.
While this difference is not as large as that which occurred 6 d after priming,
the divergence in frequencies becomes significant when normalized to the
proportion of Thy-I + (sevenfold) or Lyt-2'' (14 .5-fold) cells. This experiment
demonstrates that virus-specific pCTLs persist for many months in PP after viral
challenge. We feel that this analysis is valid, as it is likely that the precursor cells
that generate reovirus-specific CTLs in in vitro cultures are ofthe T cell lineage.
The phenotype of these pCTLs is currently under investigation.
Reynolds and coworkers (14) have suggested that two populations of T
lymphocytes can be distinguished based on their preferential recirculation path-
ways through PLN vs. the gut mucosa. We should be able to determine whether
gut immunization generates a population of antigen-reactive T cells that pref-
erentially repopulate mucosal tissues by adoptive transfer experiments aimed at
determining which tissue source and which route of priming is most efficient at
populating mucosal vs. nonmucosal tissues with virus-specific T cells. That such
preferential population of PP vs. PLN occurs after enteric immunization is
suggested by the minimal response observed in PLN in bulk and limiting cultures
6 d after priming. We will expand our studies to include the lamina propria and
intraepithelial compartments for analysis, as these compartments have been
described as containing cytotoxic effectors against a variety of targets (46, 47).
Enriching for populations of lymphocytes bearing high or low levels of the MEL-
14 antigen, which is associated with binding to PLN but not PP venule high
endothelium (48), should enable us to specifically probe for subpopulations of
lymphocytes that may display preferential tissue lodging after being primed by
antigenic stimuli at different locations.
In this report, we have found that PP lymphocytes are capable of generating
cytotoxic activity to the NK cell target Yac-1 upon in vitro culture with condi-
tioned medium. This cytotoxicity to Yac-1 targets is generated from reovirus
1 /L-primed as well as control PP. Whilewe do not claim these cultured effectors
to be classic NK cells, their presence was unexpected because PP have been
described as poor sources for NK cytotoxicity (49). The finding of this type of
activity from in vitro-cultured PP indicates that precursor populations for these
nonspecific cytotoxic cells occur in PP. It is possible that these precursor popu-
lations, when activated in the patch, migrate and develop into functionally
competent lytic cells in other tissues. If this is the case, it would be similar to the
observation that PP lack terminally differentiated B cells (plasma cells) even
though they are capable of generating antibody secreting cells in in vitro cultures
(50).
The ability of enterically applied reovirus 1/L to generate a CTL response in
PP that can persist for many months demonstrates that a CTL response exists
among the repertoire of immune responses that can occur in PP. For viruses
that initially impinge on the wet epithelium, the presence of virus-specific CTLs
and natural effector (i.e., NK) cells at this location could result in the local
containment of the infectious agent before its dissemination . The ability to844
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mount a mucosal CTL response may be advantageous to the host, because local
containment would prevent sequelae associated with infection at distal sites.
Summary
In this report we have shown that reovirus I/L is an effective mucosal
immunogen capable of generating a cytotoxic T cell (CTL) and associated helper
T cell response to the nominal antigens associated with reovirus I/L. The
effectors that mediate reovirus-specific cytotoxicity are Thy-I''', Lyt-2''', and
major histocompatibility complex (MHC)-restricted in their recognition of reo-
virus antigens, and can therefore be classified as CTLs. Frequency analysis of
precursor CTLs occurring in Peyer's patches (PP) and peripheral lymph nodes
(PLN) 6 d and 6 mo after intraduodenal stimulation have demonstrated that a
persistent gradient of precursors is established, with higher frequencies present
in PP. The generation of a CTL response in PP may be important in preferen-
tially repopulating mucosal tissues with effector CTLs that could result in the
local containment of infections in the gut.
We also found that reovirus 1/L generates a virus-specific B cell response that
is dominated by IgA memory cells after intraduodenal immunization. We hy-
pothesize that the efficacy of reovirus I/L at stimulatingT and B cells in the gut
mucosa is related to its ability to selectively enter PP via microfold (M) cells after
enteric application .
In this study we have also demonstrated that PP cells, upon in vitro culture
and unrelated to prior reovirus priming, can generate natural killer-like (NK)
cytotoxic activity. This may be an in vitro correlate of the in vivo generation of
effectors that may populate mucosal tissues (i.e., the intestinal epithelium) with
NK-like effector cells.
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